The DSRU had a great conference at ICPE (International Conference on Pharmacoepidemiology & Therapeutic Risk Management) in Copenhagen last week. The in-person annual conference of the International Society for Pharmacoepidemiology (ISPE) returned after a 2 year break. We had a busy few days presenting our research, meeting delegates at our exhibition booth and reconnecting with colleagues old and new. The DSRU team was glad to hear about the latest progress in pharmacoepidemiology and to exchange ideas with colleagues from around the world without worrying about Teams or Zoom!
Samantha Lane (Senior Research Fellow) and Dr Alison Yeomans (Research Fellow) presented their research looking at whether immunocompromised people are more likely to suffer myocarditis or pericarditis after COVID-19 mRNA vaccination than the rest of the population:
Poster 290: Myocarditis and Pericarditis in Immunocompromised Individuals Following COVID-19 mRNA Vaccination: A Living Review of Spontaneous Reports. Samantha Lane, Alison Yeomans and Saad Shakir
Meanwhile Dr Debabrata Roy (Head of Epidemiology & Research) and the other VAC4EU partners presented initial findings from their active safety surveillance study on the Pfizer Covid-19 vaccine:
Poster 301: VAC4EU active safety surveillance study of the BNT162b2 COVID-19 vaccine in five European countries: study design and first results. David Weibel, Miriam Sturkenboom, Rene Eijkemans, Rutger van den Bor, Roel Elbers, Estel Plana, Xabier Garcia de Albeniz, Rachel Weinrib, Natasha Yefimenko, Beatriz Poblador-Plou, Elisa Bianchini, Luca Stona, Karin Swart, Claudia C. Bartolini, Giulia Hyeraci, Debabrata Roy, Angela Lupattelli, Felipe Villalobos, Elisa Barbieri, Renu Garg, Heather Rubino, Cynthia De Luise, Alejandro Arana